Eledon Pharmaceuticals In... (ELDN)
NASDAQ: ELDN
· Real-Time Price · USD
2.63
0.03 (1.15%)
At close: Aug 15, 2025, 3:59 PM
2.63
0.19%
After-hours: Aug 15, 2025, 07:54 PM EDT
Eledon Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 192K | 192K | 560K | 560K | 560K | 560K | n/a | n/a | n/a | n/a | 120.00 | 120.00 | 120.00 | 120.00 | 120K | 240K | 240K |
Cost of Revenue | 97K | 192K | 286K | 380K | 377K | 374K | 373K | 372K | 372K | 373K | 341K | 292K | 242K | 195K | 134K | 90K | 46K |
Gross Profit | 95K | n/a | 274K | 180K | 183K | 186K | -373K | -372K | -372K | -373K | -340.88K | -291.88K | -241.88K | -194.88K | -14K | 150K | 194K |
Operating Income | -77.48M | -70.39M | -56.22M | -46.91M | -42.76M | -43M | -91.35M | -90.75M | -89.68M | -88.43M | -39.13M | -39.03M | -37.72M | -36.87M | -33.83M | -29.47M | -24.09M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -18.62M | -22.42M | 12.14M | -75.18M | -39.85M | -40.33M | -89.08M | -89.21M | -88.87M | -87.97M | -38.97M | -39M | -37.72M | -36.86M | -33.78M | -29.42M | -24.04M |
Net Income | -19.05M | -22.85M | 12.14M | -75.18M | -39.85M | -39.99M | -88.41M | -88.41M | -88.04M | -87.47M | -38.23M | -37.7M | -35.88M | -34.51M | -31.6M | -27.93M | -23.13M |
Selling & General & Admin | 19.59M | 18.52M | 14.93M | 14.2M | 12.96M | 12.59M | 12.21M | 12.09M | 12.47M | 12.7M | 13.11M | 12.81M | 13M | 13.13M | 13.25M | 14.13M | 11.67M |
Research & Development | 58.09M | 51.96M | 41.1M | 32.51M | 29.61M | 30.31M | 30.5M | 30.02M | 28.56M | 27.08M | 26.01M | 26.22M | 24.72M | 23.73M | 20.59M | 13.55M | 10.14M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 36K | 31K | 31K | 34K | -3K | 7K | 47K | 48K | 54K |
Operating Expenses | 77.67M | 70.48M | 56.03M | 46.72M | 42.57M | 42.91M | 42.7M | 42.1M | 41.03M | 39.78M | 39.13M | 39.03M | 37.72M | 36.87M | 33.84M | 27.68M | 21.81M |
Interest Expense | n/a | n/a | 338K | 338K | 338K | 338K | n/a | n/a | n/a | 5K | 5K | 5K | 5K | n/a | 4.83M | 4.83M | 4.83M |
Selling & Marketing Expenses | n/a | -95K | -189K | -189K | -189K | -94K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 59.71M | 70.58M | 56.22M | 46.91M | 42.76M | 43M | 42.7M | 42.1M | 41.03M | 39.78M | 39.13M | 39.03M | 37.72M | 36.87M | 33.84M | 27.68M | 21.81M |
Income Tax Expense | -431K | -379.28K | 101.91K | 101.91K | 73.83K | -315.9K | -701.09K | -828.09K | -836K | -493K | -737K | -1.3M | -1.85M | -2.35M | -2.19M | -1.5M | -915K |
Shares Outstanding (Basic) | 77.13M | 59.79M | 51.95M | 42.28M | 29.99M | 24.21M | 29.97M | 24.01M | 14.29M | 13.78M | 14.27M | 14.27M | 14.33M | 14.31M | 14.82M | 14.82M | 14.83M |
Shares Outstanding (Diluted) | 771.27M | 59.79M | 55.48M | 42.28M | 29.99M | 24.21M | 29.97M | 24.01M | 14.29M | 13.78M | 14.27M | 14.27M | 14.33M | 14.82M | 14.82M | 14.82M | 14.83M |
EPS (Basic) | -0.44 | -0.7 | -2.14 | -2.15 | -1.49 | -1.88 | -5.69 | -6.07 | -6.32 | -6.28 | -2.69 | -2.62 | -2.47 | -2.35 | -9.92 | -14.77 | -17.01 |
EPS (Diluted) | -1.36 | -1.62 | -2.12 | -2.15 | -1.49 | -1.88 | -5.69 | -6.07 | -6.32 | -6.28 | -2.66 | -2.59 | -2.44 | -2.32 | -9.92 | -14.77 | -17.01 |
EBITDA | -77.41M | -70.22M | -55.85M | -46.53M | -42.38M | -42.63M | -42.33M | -41.73M | -40.66M | -39.41M | -38.78M | -38.74M | -37.48M | -36.67M | -33.61M | -28.53M | -22.7M |
EBIT | -59.71M | -70.58M | -56.22M | -46.91M | -42.76M | -43M | -42.7M | -42.1M | -41.03M | -39.78M | -39.13M | -39.03M | -37.72M | -36.87M | -33.79M | -27.63M | -21.76M |
Depreciation & Amortization | 264K | 359K | 365K | 380K | 377K | 374K | 373K | 372K | 372K | 373K | 341K | 292K | 242K | 195K | 179K | 181K | 183K |